Concepedia

Lori J. Wirth

LJ

166

Publications

17.9K

Citations

64

H-Index

1993

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Institut Gustave Roussy

Lori J. Wirth is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1993–2025

166

Publications

166

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger, Makoto Tahara, Lori J. Wirth et al. · New England Journal of Medicine · 2015 · 2K citations · Full text

Cabozantinib in Progressive Medullary Thyroid Cancer

Rossella Elisei, Martin Schlumberger, Stefan Müller et al. · Journal of Clinical Oncology · 2013 · 1.2K citations · Full text

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth, Eric J. Sherman, Bruce Robinson et al. · New England Journal of Medicine · 2020 · 731 citations · Full text

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister et al. · Journal of Clinical Oncology · 2017 · 641 citations · Full text

, , +20

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Harold J. Burstein, Lada Krilov, Jeanny B. Aragon‐Ching et al. · Journal of Clinical Oncology · 2017 · 599 citations

, , +16

Rows per page

1–5 of 166